The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation
Radiotherapy and Oncology. 1989;16(2):121-128 
Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor–alpha
Cancer. 1993;72(3):809-818
cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment
Biochemical Pharmacology. 1986;35(4):607-611
Cisplatin (cis-diamminedichloroplatinum II)
Cancer Treatment Reviews. 1979;6(1):17-39
Analysis of Histopathology of the Irradiated Adult Rat Brain During First 3 Post-Irradiation Months: Expression of Protein Kinase C and the Role of Apoptosis in Radiation Encephalopathy
The Ewha Medical Journal. 1995;18(4):323
Phase II study of 5-day continuous infusion of cis-diamminedichloroplatinum(II) in the treatment of non-small-cell lung cancer
Lung Cancer. 1991;7(4):276
Enhanced levels of cyclic AMP, adenosine(5′)tetraphospo(5′)adenosine and nucleoside 5′-triphosphates in mouse leukemia P388/D1 after treatment with cis-diamminedichloroplatinum(II)
Biochemical Pharmacology. 1991;42(2):285-294
Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chrom
Journal of Chromatography A. 1987;407:253-272
DNA degradation after interaction of cis- and trans-diamminedichloroplatinum (II) with calf thymus nuclei
Molecular Biology Reports. 1986;11(1):25-28
Analysis of the Histopathology of the Irradiated Rat Brain with or Without Cisplatin in the First Post-Irradiation Month
The Ewha Medical Journal. 1995;18(3):169